Results 241 to 250 of about 24,860,034 (345)

De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells. [PDF]

Viruses
Enya B, Skowronski J.
europepmc   +1 more source

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Nature, 2015
M. Caskey, F. Klein, J. C. Lorenzi, M. Seaman, A. West, Noreen Buckley, G. Kremer, Lilian Nogueira, Malte Braunschweig, J. Scheid, J. Horwitz, I. Shimeliovich, Sivan Ben-Avraham, M. Witmer-Pack, M. Platten, C. Lehmann, L. Burke, T. Hawthorne, R. Gorelick, B. Walker, T. Keler, R. Gulick, G. Fätkenheuer, S. Schlesinger, M. Nussenzweig   +24 more
semanticscholar   +1 more source

Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Long‐acting cabotegravir is approved for HIV treatment and prevention. To guide management of dosing deviations and interruptions, concentration‐time profiles for monthly and every 2 months regimens were simulated using a population pharmacokinetic (PPK) model.
Kelong Han, Ronald D. D'Amico, William R. Spreen, Susan L. Ford   +3 more
wiley   +1 more source

Microtubule acetylation is not required for HIV-1 infection or TRIM69-mediated restriction of HIV-1 infection. [PDF]

J Virol
Lichon DM, LoMascolo NJ, Mounce BC, Campbell EM.   +3 more
europepmc   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

Social Perceptions of Protection against HIV Infection among Female Street Prostitutes.

Iranian Journal of Public Health, 2014
Saeedeh Moayedi-Nia, Mohsen Naserirad, Banafshe Moradmand Badie, Asiye Ghorbani, Minoo Mohraz   +4 more
doaj  

Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy. [PDF]

Viruses
Hasson JM, Katusiime MG, Capoferri AA, Bale MJ, Luke BT, Shao W, Cotton MF, van Zyl G, Patro SC, Kearney MF.   +9 more
europepmc   +1 more source

Detection of HIV-1 by polymerase chain reaction and culture in seronegative intravenous drug users in an inner-city emergency department

, 1993
Gabor D. Kelen, Arjun Chanmugam, William A. Meyer, H. Farzadegan, Daniel Stone, Thomas C. Quinn   +5 more
openalex   +1 more source

Family's socioeconomic and demographic factors on elements of children's dental and oral health: A scoping review

Clinical and Experimental Dental Research, EarlyView.
Abstract Background Family plays a significant role in children's dental and oral health (DOH) elements, such as children's DOH knowledge and practice, the development of children's dental fear and anxiety (DFA), children's dental visits, and children's DOH status.
Wisnu Fadila, Mugia B. Rahardja, Puguh Prasetyoputra, Anne A. Suwargiani, Yanu E. Prasetyo, Eriska Riyanti   +5 more
wiley   +1 more source

Transcriptomic HIV-1 reservoir profiling reveals a role for mitochondrial functionality in HIV-1 latency. [PDF]

PLoS Pathog
Man S, Jansen J, Kroeze S, Geijtenbeek TBH, Kootstra NA.   +4 more
europepmc   +1 more source